The following are some of the biotech companies that posted quarterly earnings and provided a business update on Thursday.
1. ABIOMED Inc. (ABMD) expects its revenue for fiscal year 2023 to grow 11% to 15% on a reported basis compared to fiscal year 2022.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com